An employee’s itchy social media trigger finger has been ruled to put AstraZeneca UK Limited (AZ) in breach of multiple clauses of a pharma industry code of practice.
The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued its final resolution in a 2025 case related to when an
The
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day

